Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model and mechanistic study with no human data
PubMed 28017795 · doi:10.1016/j.stem.2016.11.020
What was done
Researchers evaluated whether acute or chronic muscle injury enables transcription-factor-mediated in vivo cellular reprogramming in skeletal muscle. They utilized lineage tracing to identify the cellular origin of reprogramming and examined the role of senescent cells and their secretome (including IL-6) by testing the effects of advanced aging, local irradiation, and targeted senescent cell ablation.
What was found
The abstract reports no numerical data, effect sizes, or p-values. Qualitatively, skeletal muscle injury allowed in vivo reprogramming, primarily originating from Pax7+ muscle stem cells. Aging and local irradiation enhanced reprogramming efficiency, whereas selective clearance of senescent cells reduced it. The pro-reprogramming effect of senescence was linked in part to paracrine release of IL-6.
Why it matters
This study shows that injury-induced senescence and the senescence-associated secretory phenotype (SASP) can promote cellular plasticity rather than solely impairing tissue function, identifying IL-6 as a facilitator of in vivo muscle reprogramming.
Limits
The study is entirely preclinical (animal models), with no human data. The abstract provides no sample sizes, effect magnitudes, or variance metrics. The balance between beneficial plasticity and oncogenic or degenerative risks of senescent secretomes was not detailed.
Cited by
- supports Senescent cells secrete factors and growth factors that can promote cell reprogramming and stimulate tissue regeneration in neighboring cells.